Aclarion, Inc.
Close on Oct 19, 2026
- Market cap
- $4.65M
- P/E (TTM)
- –
- Dividend yield
- –
About Aclarion
Services-Medical Laboratories, SIC 8071
Aclarion, Inc. is a healthcare technology company that utilizes Magnetic Resonance Spectroscopy and proprietary biomarkers to enhance clinical treatments for back and neck pain. Its proprietary software transforms spectroscopy signal data into biomarkers to help determine whether an intervertebral disc is a source of chronic pain. The company primarily targets chronic discogenic low back pain by assisting spine surgeons in selecting optimal surgical interventions.
Operating within the medical technology sector, Aclarion focuses on the chronic low back and cervical spine pain markets. Its diagnostic software serves clinicians and surgical teams seeking objective, noninvasive evaluation of lumbar discs prior to operative intervention. As of the report date, the company maintains its principal executive offices in Broomfield, Colorado.
Summary of the business section of Aclarion's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Aclarion, Inc.
- Headquarters
- Broomfield, CO
- Address
- 8181 Arista Place, Ste 100 80021
- Phone
- (833) 275-2266
- Employees
- 11, Dec 31, 2025
- Industry
- Services-Medical Laboratories
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Haynie & Company, Salt Lake City, Utah
Stock & identifiers
- Ticker
- ACON
- Other tickers
- ACONW
- Exchange
- Nasdaq
- IPO date
- Apr 25, 2022
- Shares outstanding
- 3M, Aug 4, 2026
- Public float
- $4.39M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Stock splits
- 1-for-9047 reverse, Apr 9, 2025; 1-for-27 reverse, Mar 28, 2025; 1-for-335 reverse, Jan 30, 2025; 1-for-16 reverse, Mar 28, 2024; 1-for-16 reverse, Jan 4, 2024
- SEC CIK
- 1635077
- CUSIP
- 655187409
- ISIN
- US6551874091
- LEI
- 529900MGK6H51761Z546
- EIN
- 47-3324725
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Brent Ness | Chief Executive Officer, Director | 111,534 |
| Jeffrey John Thramann | Executive Chairman, Director | 100,000 |
| Gregory A. Gould | CFO | 60,000 |
| Amanda Mae Sequira | Director | 25,857 |
| William Wesemann | Director | 23,713 |
| David K. Neal | Director | 30,002 |
| Ryan Bond | Director | 76,122 |
| Stephen Deitsch | Director | 20,000 |
| Scott Breidbart | Director | 25,664 |
Employees
Headcount reported in annual reports
“As of January 1, 2026, we had 11 total employees,”
Corporate history
Events identified from SEC filings